Early Discontinuation of Buprenorphine Therapy for Opioid Use Disorder Among Privately Insured Adults

Abstract

Poorer treatment retention among privately insured adults was associated with greater clinical and financial burdens that preceded and continued during the period shortly following treatment initiation, suggesting that cost burdens may contribute to poor retention among privately insured adults.